The Medicines and Healthcare product Regulatory Agency (MHRA) has made the latest Current Problems in Pharmacovigilance available online. An index of recent issues dating back to 2001 is also available.
The latest issue details over 20 separate issues including:
- Cancer risk with tacrolimus and pimecrolimus
- HRT and risk of endometrial cancer
- Jaw osteonecrosis with bisphosphonates
- Optic neuropathy with linezolid
Action: Current Problems in Pharmacovigilance is a must read for all clinicians to raise awareness of new prescribing issues, interactions and potential adverse events brought to light through post-marketing surveillance.
|« SMC reject Esomeprazole||Advantage ii Renamed »|